Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Ingrid Grummt is "2010 Woman in Science" - DKFZ Researcher Wins 2010 Women in Science Award

No. 04 | 10/02/2010 | by (Sel)

The European Molecular Biology Organization (EMBO) and the Federation of European Biochemical Societies (FEBS) announced Ingrid Grummt from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) in Heidelberg, Germany, as the winner of the Women in Science Award. Ingrid Grummt has made important contributions to the field of gene regulation throughout her science career. The 2010 FEBS/EMBO Women in Science Award of 10,000 euro will be presented on 30 June at the 35th FEBS Congress in Gothenburg, Sweden.

Prof. Ingrid Grummt

The FEBS/EMBO Women in Science Award, now in its third year, recognizes and rewards an exceptional female researcher in molecular biology. Winners of the award are role models who inspire future generations of women in science.

“Ingrid Grummt is an outstanding scientist who has made seminal contributions in the field of regulation of gene activity throughout her career. This includes her very recent discoveries that link processes in ageing and in some inherited diseases with the silencing of genes required for cell growth,” said selection committee member Claudio Sunkel, Director of the Institute of Molecular and Cellular Biology in Porto, Portugal. The award winner is distinguished not only for her scientific contributions but also for her commitment to the development of European science. Grummt is a member of various international advisory boards, panels and scientific committees.

“It is important to me to inspire young women to face personal and professional challenges,” said the award winner, who is married to a professor of biochemistry, is a mother of a daughter and already has two grandchildren. “I am deeply convinced that integrating career and personal goals makes people happier and more productive in the long run!”

Prior to joining DKFZ in 1990, Ingrid Grummt was a post-doctoral fellow at the German Academy of Sciences in Berlin and the Max Planck Institute of Biochemistry in Munich, and led a research group at the University in Würzburg, Germany. She was honored for her research work with several awards including the Gottfried Wilhelm Leibniz Prize. In 2008, Grummt was awarded an ERC Advanced Grant, a generous grant by the European Research Council.

“I am a big fan of Ingrid Grummt,” admitted Otmar Wiestler, Scientific Director of the German Cancer Research Center. “In the first year of her ‘extension’ she is still at the top level of science!” Aged 66, Ingrid Grummt is already entitled to retirement, but she asked the management board for a three-year extension of her employment at DKFZ. In her private life, Ingrid Grummt also likes to be at the top: She just returned from a three-week tour in the Himalayas.

A picture for this press release is available on the Internet at

With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.

To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:

  • National Center for Tumor Diseases (NCT, 6 sites)
  • German Cancer Consortium (DKTK, 8 sites)
  • Hopp Children's Cancer Center (KiTZ) Heidelberg
  • Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
  • DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
  • National Cancer Prevention Center (jointly with German Cancer Aid)
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.


Subscribe to our RSS-Feed.

to top
powered by webEdition CMS